Crescent Biopharma (CBIO) Total Non-Current Liabilities (2013 - 2021)
Crescent Biopharma's Total Non-Current Liabilities was $10.84 million in Q3 2021, down 9.5% from $11.97 million a year earlier and down 7.2% from the prior quarter.
Crescent Biopharma (CBIO) Total Non-Current Liabilities (2013 - 2021) Analysis & Trends
At the end of FY2020, Total Non-Current Liabilities at Crescent Biopharma came in at $14.35 million.
- Total Non-Current Liabilities shows a five-year compound annual growth rate of 13.1% (FY2015 to FY2020).
- In earlier years, Total Non-Current Liabilities was $8.76 million in FY2018 (+7.2%), $8.17 million in FY2017 (+29.1%) and $6.33 million in FY2016 (-18.2%).
- The Q3 2021 figure marks the lowest quarterly Total Non-Current Liabilities since Q4 2018.
- Compared with a year earlier, Total Non-Current Liabilities has declined for three straight quarters.
- The best year-over-year quarter for Total Non-Current Liabilities over five years was Q1 2018 (growth of 93.0%); the worst was Q1 2017 (a decline of 21.5%).
- Per Business Quant data, CBIO's Total Non-Current Liabilities in the three quarters before Q3 2021 was $11.68 million (Q2 2021), $12.52 million (Q1 2021) and $14.35 million (Q4 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Crescent Biopharma | 401.19 Mn | -306.10 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 10.84 Mn |
| Jun 30, 2021 | 11.68 Mn |
| Mar 31, 2021 | 12.52 Mn |
| Dec 31, 2020 | 14.35 Mn |
| Sep 30, 2020 | 11.97 Mn |
| Jun 30, 2020 | 12.09 Mn |
| Mar 31, 2020 | 13.22 Mn |
| Dec 31, 2018 | 8.76 Mn |
| Sep 30, 2018 | 5.70 Mn |
| Jun 30, 2018 | 6.29 Mn |
| Mar 31, 2018 | 7.93 Mn |
| Dec 31, 2017 | 8.17 Mn |
| Sep 30, 2017 | 5.73 Mn |
| Jun 30, 2017 | 4.63 Mn |
| Mar 31, 2017 | 3.71 Mn |
| Dec 31, 2016 | 6.33 Mn |
| Sep 30, 2016 | 4.50 Mn |
| Jun 30, 2016 | 5.21 Mn |
| Mar 31, 2016 | 5.68 Mn |
| Dec 31, 2015 | 7.75 Mn |
Crescent Biopharma Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CBIO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "CBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();